We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.35% | 1,432.00 | 1,438.00 | 1,440.00 | 1,443.00 | 1,423.00 | 1,425.00 | 162,652 | 16:35:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 971.62 | 1.95B |
TIDMINDV
RNS Number : 4272V
Indivior PLC
02 November 2017
Indivior PLC - Board Committee Changes
Slough, UK and Richmond, VA, November 2, 2017 - Indivior PLC (LON: INDV) announces that Daniel Tassé, Senior Independent Director, has been appointed a member of the Remuneration Committee and has stepped down from the Science and Policy Committee.
Lizabeth Zlatkus has been appointed a member of the Science and Policy Committee and has stepped down from the Remuneration Committee.
All changes became effective on November 1, 2017 and, as a result, the membership of these committees is now as follows:
Remuneration Committee
Daniel J Phelan (Chair)
Tatjana May
Lorna Parker
Daniel Tassé
Science & Policy Committee
Yvonne Greenstreet (Chair)
A. Thomas McLellan
Chris Schade
Lizabeth Zlatkus
This announcement is made in accordance with Listing Rule 9.6.11.
Kathryn Hudson
Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCXLLFBDFFLFBE
(END) Dow Jones Newswires
November 02, 2017 09:28 ET (13:28 GMT)
1 Year Indivior Chart |
1 Month Indivior Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions